Testosterone Lawsuit News: Bernstein Liebhard LLP Notes FDA Alert Regarding Potential for Blood Clot
The Firm is evaluating testosterone treatment lawsuits on behalf of men who may have suffered life-threatening cardiovascular injuries, including heart attacks, strokes and blood clots, due to low testosterone therapy. New York, NY (PRWEB) June 23, 2014 As testosterone lawsuit (http://www.testosteronelawsuitclaims.com/) filings continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the Food & Drug Administration (FDA) is warning of a potential risk for venous blood clots among men who use low testosterone therapy medications. According to an FDA alert dated June 20, 2014,
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 313
- Bankruptcy 44
- Business 135
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 609
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4